[Experience with the use of papaverolina in patients with arterial diseases].
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001783:Blood Flow Velocity; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000031:analogs & derivatives*; D010992:Plethysmography, Impedance; D013765:Tetrahydropapaveroline / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013765:Tetrahydropapaveroline; C011054:papaveroline; D010208:Papaverine
Esperienze sull'uso della papaverolina negli arteriopatici.